RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 87 filers reported holding RELMADA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $29,929,000 | -44.3% | 935,000 | -38.7% | 0.52% | -43.8% |
Q1 2021 | $53,695,000 | +9.8% | 1,525,000 | 0.0% | 0.93% | +10.1% |
Q4 2020 | $48,907,000 | -13.3% | 1,525,000 | +1.7% | 0.84% | +5.0% |
Q3 2020 | $56,430,000 | -11.5% | 1,500,000 | +5.3% | 0.80% | -36.4% |
Q2 2020 | $63,769,000 | +62.6% | 1,425,000 | +23.9% | 1.26% | -4.8% |
Q1 2020 | $39,227,000 | – | 1,150,000 | – | 1.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 668,440 | $25,147,000 | 4.92% |
TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,810,000 | 3.40% |
ACUTA CAPITAL PARTNERS, LLC | 277,000 | $10,421,000 | 2.83% |
PARSONS CAPITAL MANAGEMENT INC/RI | 455,137 | $17,122,000 | 1.67% |
RTW INVESTMENTS, LP | 1,511,337 | $56,857,000 | 1.37% |
Avoro Capital Advisors LLC | 1,500,000 | $56,430,000 | 0.80% |
Pegasus Asset Management, Inc. | 26,958 | $1,014,000 | 0.64% |
RA Capital Management | 781,290 | $29,392,000 | 0.54% |
TIEDEMANN ADVISORS, LLC | 269,839 | $10,151,000 | 0.49% |
Boxer Capital, LLC | 300,000 | $11,286,000 | 0.39% |